Development Level

Tchem 4 | 1,598
Tclin 4 | 613
Tdark 3 | 6,588
Tbio 2 | 11,445

IMPC Phenotype

abnormal retinal blood vessel ... 1 | 26
abnormal skin coloration 1 | 25
female infertility 1 | 60
male infertility 1 | 123

Disease

Carcinoma 9 | 11,493
atypical teratoid / rhabdoid tumor 7 | 5,112
ependymoma 6 | 4,679
interstitial cystitis 6 | 2,312
medulloblastoma, large-cell 6 | 6,241
group 3 medulloblastoma 5 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,955
osteosarcoma 5 | 7,950
psoriasis 5 | 6,694
Multiple Sclerosis 4 | 540
Relapsing remitting multiple sclerosis 4 | 14
astrocytic glioma 4 | 2,597
glioblastoma 4 | 5,792
group 4 medulloblastoma 4 | 1,855
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
ovarian cancer 4 | 8,520
primitive neuroectodermal tumor 4 | 3,035
Astrocytoma, Pilocytic 3 | 3,081
Cancer 3 | 2,499
Diabetes Mellitus, Experimental 3 | 108
adult high grade glioma 3 | 3,801
lung adenocarcinoma 3 | 2,716
non-small cell lung cancer 3 | 2,890
pancreatic cancer 3 | 2,398
Dental caries 2 | 164
Lymphopenia 2 | 67
Pick disease 2 | 1,894
Vascular disease 2 | 319
cystic fibrosis 2 | 1,696
invasive ductal carcinoma 2 | 2,951
lung cancer 2 | 4,740
oligodendroglioma 2 | 2,850
pediatric high grade glioma 2 | 1,064
primary Sjogren syndrome 2 | 735
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis 2 | 2,010
Animal Mammary Neoplasms 1 | 136
Atherosclerosis 1 | 291
Autosomal recessive nonsyndromic deafness 68 1 | 4
Autosomal recessive predisposition 1 | 1,442
Bipolar Disorder 1 | 666
Breast cancer 1 | 3,578
DEAFNESS, AUTOSOMAL RECESSIVE 68 1 | 1
Endometriosis 1 | 540
Globe disease 1 | 67
Heart Diseases 1 | 43
Infantile onset 1 | 238
Kidney cancer 1 | 2,613
Liver Cirrhosis, Experimental 1 | 769
Mammary Neoplasms, Animal 1 | 136
Mammary Neoplasms, Experimental 1 | 154
Neoplasm Invasiveness 1 | 161
Nonsyndromic deafness 1 | 142
Parkinson's disease 1 | 392
Pseudohypoparathyroidism 1 | 18
Retinitis pigmentosa 12 1 | 9
Scleroderma, Systemic 1 | 13
Seizures 1 | 596
Sensorineural Hearing Loss (disorder) 1 | 284
Type 1 diabetes mellitus 1 | 109
X-linked cerebral adrenoleukodystrophy 1 | 116
active Crohn's disease 1 | 922
astrocytoma 1 | 1,146
atypical teratoid/rhabdoid tumor 1 | 357
breast carcinoma 1 | 1,638
chronic lymphosyte leukemia 1 | 204
cutaneous lupus erythematosus 1 | 1,057
ductal carcinoma in situ 1 | 1,745
fibroadenoma 1 | 559
hepatocellular carcinoma 1 | 547
interstitial lung disease 1 | 298
lung carcinoma 1 | 2,843
malignant mesothelioma 1 | 3,232
nephrosclerosis 1 | 333
non primary Sjogren syndrome sicca 1 | 891
pancreatic carcinoma 1 | 562
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 416
primary pancreatic ductal adenocarcinoma 1 | 1,109
type I diabetes mellitus 1 | 22
ulcerative colitis 1 | 1,819

Tissue

Digestive Tract 13 | 17,369
Endocrine System 13 | 18,159
Female tissues 13 | 17,400
Liver and Pancreas 13 | 16,750
Male tissues 13 | 17,142
Nervous System 13 | 16,725
Respiratory system 13 | 16,393
Blood and immune system 11 | 16,909
Urinary Tract 11 | 16,678
Cardiovascular System 10 | 15,192
Skin and soft tissues 10 | 17,230

Target Family

GPCR 8 | 408
Enzyme 5 | 4,145

Reactome Pathway

Lysosphingolipid and LPA recep... 13 | 13
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Lysophosphatidic acid receptor 3 LPAR3 Tchem GPCR -2.11449 131.9 238
Sphingosine 1-phosphate receptor 5 S1PR5 Tclin GPCR -1.70131 47.1 273
Lysophosphatidic acid receptor 5 LPAR5 Tchem GPCR -1.48909 32.2 126
Phospholipid phosphatase-related protein type 4 PLPPR4 Tbio Enzyme -1.15591 13.7 92
Phospholipid phosphatase-related protein type 5 PLPPR5 Tdark Enzyme -0.07918 1.14 87
Phospholipid phosphatase-related protein type 3 PLPPR3 Tbio Enzyme -1.11680 11.9 86
Sphingosine 1-phosphate receptor 3 S1PR3 Tclin GPCR -2.25158 157.8 392
Lysophosphatidic acid receptor 2 LPAR2 Tchem GPCR -1.98394 89.3 265
Sphingosine 1-phosphate receptor 4 S1PR4 Tclin GPCR -1.78966 58.4 256
Phospholipid phosphatase-related protein type 2 PLPPR2 Tdark Enzyme 0.30 0.58 56